Susan E. Shoaf, Patricia Bricmont, & Jennifer Repella Gordon. (2021). Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters. Wiley.
Chicago Style (17th ed.) CitationSusan E. Shoaf, Patricia Bricmont, and Jennifer Repella Gordon. Regulatory Guidelines Do Not Accurately Predict Tolvaptan and Metabolite Interactions at BCRP, OATP1B1, and OAT3 Transporters. Wiley, 2021.
MLA (9th ed.) CitationSusan E. Shoaf, et al. Regulatory Guidelines Do Not Accurately Predict Tolvaptan and Metabolite Interactions at BCRP, OATP1B1, and OAT3 Transporters. Wiley, 2021.
Warning: These citations may not always be 100% accurate.